Elequin Capital »

Halozyme Therapeutics shares owned by Elequin Capital

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Elequin Capital from 13F filings

Historical chart of Elequin Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Elequin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Elequin Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 273k 40.83
2023-06-30 $6.9k 190 36.07
2022-09-30 $19k 468 40.60
2022-06-30 $14k 315 44.44
2022-03-31 $9.0k 226 39.82